
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
In the modern era of safe and effective oral treatment of male erectile dysfunction, urologists may overlook the importance of a thorough patient evaluation.





